Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
We showed previously that the intracellular transport of sphingolipids (SLs) is altered in SL storage disease fibroblasts, due in part to the secondary accumulation of free cholesterol. In the present study we examined the mechanism of cholesterol elevation in normal human skin fibroblasts induced by treatment with SLs. When cells were incubated with various natural SLs for 44 h, cholesterol levels increased 25-35%, and cholesterol esterification was reduced. Catabolism of the exogenous SLs was not required for elevation of cholesterol because (i) a non-hydrolyzable and a degradable SL analog elevated cellular cholesterol to similar extents, and (ii) incubation of cells with various SL catabolites, including ceramide, had no effect on cholesterol levels. Elevated cholesterol was derived primarily from low density lipoproteins (LDL) and resulted from up-regulation of LDL receptors induced by cleavage of the sterol regulatory element-binding protein-1. Upon SL treatment, cholesterol accumulated with exogenous SLs in late endosomes and lysosomes. These results suggest a model in which excess SLs present in endocytic compartments serve as a "molecular trap" for cholesterol, leading to a reduction in cholesterol at the endoplasmic reticulum, induction of sterol regulatory element-binding protein-1 cleavage, and up-regulation of LDL receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is consistent with previous observations that increasing mTORC1 signaling induced ROS production34, whereas inhibiting mTORC1 reduced ROS34–36.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [35]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
Wang, X., Sato, R., Brown, M. S., Hua, X., & Goldstein, J. L. (1994) · Cell · doi:10.1016/0092-8674(94)90234-8 · Cited by 1,013
Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/0092-8674(93)90690-r · Cited by 981
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport
Kobayashi, T., Beuchat, M.-H., Lindsay, M., Frias, S., Palmiter, R. D., Sakuraba, H., Parton, R. G., & Gruenberg, J. (1999) · Nature Cell Biology · doi:10.1038/10084 · Cited by 620
Neufeld, E. B., Wastney, M., Patel, S., Suresh, S., Cooney, A. M., Dwyer, N. K., Roff, C. F., Ohno, K., Morris, J. A., Carstea, E. D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9627 · Cited by 373
Puri, V., Watanabe, R., Singh, R. D., Dominguez, M., Brown, J. C., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102084 · Cited by 317
Self-citationCholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases
Puri, V., Watanabe, R., Dominguez, M., Sun, X., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (1999) · Nature Cell Biology · doi:10.1038/14084 · Cited by 289
Self-citationIntracellular cholesterol transport
Fielding, C. J., & Fielding, P. E. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37169-8 · Cited by 289
Slotte, J. P., & Bierman, E. L. (1988) · Biochemical Journal · doi:10.1042/bj2500653 · Cited by 288
Research works printed but not linked: 3
- van Echten, 1990, Eur. J. Cell Biol., 51, 135
- Yokoyama, 1993, Cell, 75, 187, 10.1016/s0092-8674(05)80095-9 · doi:10.1016/s0092-8674(05)80095-9 · Paper page
- Diomede, 2001, Eur. Cytokine Netw., 12, 625
Cited by
Lipid traffic: floppy drives and a superhighway
Holthuis, J. C. M., & Levine, T. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1591 · Cited by 490
Kim, Y.-R., Lee, E.-J., Shin, K.-O., Kim, M. H., Pewzner-Jung, Y., Lee, Y.-M., Park, J.-W., Futerman, A. H., & Park, W.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0340-1 · Cited by 474
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Membranes in Balance: Mechanisms of Sphingolipid Homeostasis
Breslow, D. K., & Weissman, J. S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.005 · Cited by 287
Selective Stimulation of Caveolar Endocytosis by Glycosphingolipids and Cholesterol
Sharma, D. K., Brown, J. C., Choudhury, A., Peterson, T. E., Holicky, E., Marks, D. L., Simari, R., Parton, R. G., & Pagano, R. E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0189 · Cited by 271
Self-citationGenetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice
Park, T.-S., Panek, R. L., Mueller, S. B., Hanselman, J. C., Rosebury, W. S., Robertson, A. W., Kindt, E. K., Homan, R., Karathanasis, S. K., & Rekhter, M. D. (2004) · Circulation · doi:10.1161/01.cir.0000148370.60535.22 · Cited by 223
Lipidomics era: Accomplishments and challenges
Bou Khalil, M., Hou, W., Zhou, H., Elisma, F., Swayne, L. A., Blanchard, A. P., Yao, Z., Bennett, S. A. L., & Figeys, D. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20294 · Cited by 204
Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver
Bektas, M., Allende, M. L., Lee, B. G., Chen, W., Amar, M. J., Remaley, A. T., Saba, J. D., & Proia, R. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081489 · Cited by 198
Molecular determinants of endothelial transcytosis and their role in endothelial permeability
Predescu, S. A., Predescu, D. N., & Malik, A. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2006 · Cited by 188
Membrane lipids and vesicular traffic
Meer, G. V., & Sprong, H. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.06.004 · Cited by 177
Niemann-Pick Type C Disease and Intracellular Cholesterol Trafficking
Chang, T.-Y., Reid, P. C., Sugii, S., Ohgami, N., Cruz, J. C., & Chang, C. C. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r400040200 · Cited by 164
Developments in the treatment of Fabry disease
van der Veen, S. J., Hollak, C. E. M., Kuilenburg, A. B. P., & Langeveld, M. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12228 · Cited by 158
Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C
Lachmann, R. H., te Vruchte, D., Lloyd-Evans, E., Reinkensmeier, G., Sillence, D. J., Fernandez-Guillen, L., Dwek, R. A., Butters, T. D., Cox, T. M., & Platt, F. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.002 · Cited by 150
Lipid imbalance in the neurological disorder, Niemann‐Pick C disease
Vance, J. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.008 · Cited by 146
Distinct Mechanisms of Clathrin-independent Endocytosis Have Unique Sphingolipid Requirements
Cheng, Z.-J., Singh, R. D., Sharma, D. K., Holicky, E. L., Hanada, K., Marks, D. L., & Pagano, R. E. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1101 · Cited by 139
Self-citationLingwood, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004788 · Cited by 159
Defective cholesterol trafficking in Niemann‐Pick C‐deficient cells
Peake, K. B., & Vance, J. E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.047 · Cited by 122
Karten, B., Peake, K., & Vance, J. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.025 · Cited by 140
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
Nagahashi, M., Yuza, K., Hirose, Y., Nakajima, M., Ramanathan, R., Hait, N. C., Hylemon, P. B., Zhou, H., Takabe, K., & Wakai, T. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r069286 · Cited by 122
Annexin A6‐Induced Alterations in Cholesterol Transport and Caveolin Export from the Golgi Complex
Cubells, L., de Muga, S. V., Tebar, F., Wood, P., Evans, R., Ingelmo‐Torres, M., Calvo, M., Gaus, K., Pol, A., Grewal, T., et al. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00640.x · Cited by 115
Niemann–Pick type C disease: cellular pathology and pharmacotherapy
Wheeler, S., & Sillence, D. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14895 · Cited by 117
Ding, T., Li, Z., Hailemariam, T. K., Mukherjee, S., Maxfield, F. R., Wu, M.-P., & Jiang, X. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700401-jlr200 · Cited by 106
Where sterols are required for endocytosis
Pichler, H., & Riezman, H. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.05.011 · Cited by 112
Choudhury, A., Marks, D. L., Proctor, K. M., Gould, G. W., & Pagano, R. E. (2006) · Nature Cell Biology · doi:10.1038/ncb1380 · Cited by 103
Self-citationModulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice
Park, T., Panek, R. L., Rekhter, M. D., Mueller, S. B., Rosebury, W. S., Robertson, A. W., Hanselman, J. C., Kindt, E. K., Homan, R., & Karathanasis, S. K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.029 · Cited by 102
Protein transduction of Rab9 in Niemann‐Pick C cells reduces cholesterol storage
Narita, K., Choudhury, A., Dobrenis, K., Sharma, D. K., Holicky, E. L., Marks, D. L., Walkley, S. U., & Pagano, R. E. (2005) · The FASEB Journal · doi:10.1096/fj.04-2714fje · Cited by 88
Self-citationCathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux
Haidar, B., Kiss, R. S., Sarov-Blat, L., Brunet, R., Harder, C., McPherson, R., & Marcel, Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605095200 · Cited by 85
Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
Rodríguez‐Cuenca, S., Barbarroja, N., & Vidal‐Puig, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.021 · Cited by 92
Liu, M., Seo, J., Allegood, J. C., Bi, X., Zhu, X., Boudyguina, E. Y., Gebre, A. K., Avni, D., Shah, D., Sorci‐Thomas, M. G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499913 · Cited by 86
Broekman, M. L. D., Baek, R. C., Comer, L. A., Fernandez, J. L., Seyfried, T. N., & Sena-Esteves, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300004 · Cited by 79
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway
Glaros, E. N., Kim, W. S., Quinn, C. M., Wong, J., Gelissen, I., Jessup, W., & Garner, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413862200 · Cited by 75
Regulation of Intracellular Cholesterol Distribution by Na/K-ATPase
Chen, Y., Cai, T., Wang, H., Li, Z. F., Loreaux, E. L., Lingrel, J. B., & Xie, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003574 · Cited by 75
Bergheanu, S. C., Reijmers, T. H., Zwinderman, A. H., Bobeldijk, I., Ramaker, R., Liem, A. H., van der Greef, J., Hankemeier, T., & Jukema, J. W. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802321709 · Cited by 74
Renal Glycosphingolipid Metabolism Is Dysfunctional in Lupus Nephritis
Nowling, T. K., Mather, A. R., Thiyagarajan, T., Hernandez‐Corbacho, M. J., Powers, T. W., Jones, E. E., Snider, A. J., Oates, J. C., Drake, R. R., & Siskind, L. J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050508 · Cited by 76
Lipid homeostasis in macrophages – Implications for atherosclerosis
Schmitz, G., & Grandl, M. (2008) · Springer eBooks · doi:10.1007/112_2008_802 · Cited by 77
Nagao, K., Takahashi, K., Hanada, K., Kioka, N., Matsuo, M., & Ueda, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611230200 · Cited by 66
Cao, S., Fernández-Zapico, M. E., Jin, D., Puri, V., Cook, T. A., Lerman, L. O., Zhu, X.-Y., Urrutia, R. A., & Shah, V. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407941200 · Cited by 66
Self-citationRoles of sphingolipids in Drosophila development and disease
Kraut, R. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07022.x · Cited by 68
Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking
Gentzsch, M., Choudhury, A., Chang, X.-B., Pagano, R. E., & Riordan, J. R. (2007) · Journal of Cell Science · doi:10.1242/jcs.03350 · Cited by 72
Self-citationFilipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain
Arthur, J. R., Heinecke, K. A., & Seyfried, T. N. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012633 · Cited by 60
Galván, C. A., Camoletto, P. G., Cristofani, F., Veldhoven, P. P. V., & Ledesma, M. D. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0439 · Cited by 59
Ozbay, T., Rowan, A., Leon, A., Patel, P., & Sewer, M. B. (2006) · Endocrinology · doi:10.1210/en.2005-1091 · Cited by 55
Glucosylceramide modulates endolysosomal pH in Gaucher disease
Sillence, D. J. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.03.015 · Cited by 59
Itokazu, Y., Pagano, R. E., Schroeder, A. S., O’Grady, S. M., LIMPER, A. H., & Marks, D. L. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00168.2013 · Cited by 52
Self-citationKiss, R. S., Ma, Z., Nakada‐Tsukui, K., Brugnera, E., Vassiliou, G., McBride, H. M., Ravichandran, K. S., & Marcel, Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600621200 · Cited by 58
Farooqui, A. A., & Farooqui, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910672 · Cited by 56
Hagen-Euteneuer, N., Lütjohann, D., Park, H. J., Merrill, A. H., & van Echten‐Deckert, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302380 · Cited by 56
Gangliosides and β1-Integrin Are Required for Caveolae and Membrane Domains
Singh, R. D., Marks, D. L., Holicky, E. L., Wheatley, C. L., Kaptzan, T., Sato, S. B., Kobayashi, T., Ling, K., & Pagano, R. E. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.01022.x · Cited by 50
Self-citationSchmiedt, M.-L., Blom, T., Blom, T., Kopra, O., Wong, A., von Schantz-Fant, C., Ikonen, E., Kuronen, M., Jauhiainen, M., Cooper, J. D., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.009 · Cited by 47
Porubský, Š., Speak, A. O., Salio, M., Jennemann, R., Bonrouhi, M., Zafarulla, R., Singh, Y., Dyson, J., Luckow, B., Lehuen, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201483 · Cited by 53
Saito, M., Saito, M., Cooper, T. B., & Vadász, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000175011.22307.61 · Cited by 57
Fabry disease: Mechanism and therapeutics strategies
Li, X., Ren, X., Zhang, Y., Ding, L., Huo, M., & Li, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025740 · Cited by 57
Salvioli, R., Tatti, M., Scarpa, S., Moavero, S. M., Ciaffoni, F., Felicetti, F., Kaneski, C. R., Brady, R. O., & Vaccaro, A. M. (2005) · Biochemical Journal · doi:10.1042/bj20050325 · Cited by 49
Lipid Homeostasis and Lipoprotein Secretion in Niemann-Pick C1-deficient Hepatocytes
Kulinski, A., & Vance, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610001200 · Cited by 44
Kodvawala, A., Ghering, A. B., Davidson, W. S., & Hui, D. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502266200 · Cited by 46
Arkensteijn, B., Berbée, J. F. P., Rensen, P. C. N., Nielsen, L. B., & Christoffersen, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034419 · Cited by 42
Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment
Pan, X. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_9 · Cited by 41
Xu, Y., Tertilt, C., Krause, A., Quadri, L. E. N., Crystal, R. G., & Worgall, S. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-26 · Cited by 38
Makdissy, N., Haddad, K., Mouawad, C. A., Popa, I., Younsi, M. O., Valet, P., Brunaud, L., Ziegler, O., & Quilliot, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133181 · Cited by 35
Sphingolipids: major regulators of lipid metabolism
Worgall, T. S. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328028fda3 · Cited by 32
Misdiagnosis of Niemann‐Pick disease type C as Gaucher disease
Lo, S. M., McNamara, J., Mr, S., & Mistry, P. K. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9214-3 · Cited by 28
Therapeutic Uses of Bacterial Subunit Toxins
Lingwood, C. A. (2021) · Toxins · doi:10.3390/toxins13060378 · Cited by 27
Issandou, M., Guillard, R., Boullay, A.-B., Linhart, V., & Lopez‐Perez, E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.006 · Cited by 25
Sztolsztener, M. E., Dobrzyń, A., Pikuła, S., Tylki‐Szymańska, A., & Bandorowicz‐Pikuła, J. (2012) · Molecular BioSystems · doi:10.1039/c2mb05447g · Cited by 23
Niimi, N., Yako, H., Tsukamoto, M., Takaku, S., Yamauchi, J., Kawakami, E., Yanagisawa, H., Watabe, K., Utsunomiya, K., & Sango, K. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13268 · Cited by 22
Regulation of lipid metabolism by sphingolipids
Worgall, T. S. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8830-8_14 · Cited by 23
Hortsch, R., Lee, E., Erathodiyil, N., Hebbar, S., Steinert, S., Lee, J. Y., Chua, D. S. K., & Kraut, R. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0005 · Cited by 21
Kamal, M., Moshiri, H., Magomedova, L., Han, D., Nguyen, K. C. Q., Yeo, M., Knox, J., Bagg, R., Won, A. M., Szlapa, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11908-0 · Cited by 16
He, S., Gu, X., Yang, J., Xu, F., Hu, J., Wang, W., Huang, Y., Lou, B., Ding, T., Zhou, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902016 · Cited by 16
Lou, F., Li, M., Liu, N., Li, X., Ren, Y., & Luo, X. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1526796 · Cited by 10
Schueler, U., Kaneski, C. R., Remaley, A. T., Demosky, S. J., Dwyer, N. K., Blanchette‐Mackie, J., Hanover, J. A., & Brady, R. O. (2015) · JIMD Reports · doi:10.1007/8904_2015_507 · Cited by 9
Milis, D. G., Moore, M. K., Atshaves, B. P., Schroeder, F., & Jefferson, J. R. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-2270-1 · Cited by 9
Self-citationCorrelations Between Serum Cholesterol and Vascular Lesions in Fabry Disease Patients
Katsuta, H., Tsuboi, K., Yamamoto, H., & Goto, H. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0378 · Cited by 8
Cheng, Z.-J., Singh, R. D., Wang, T.-K., Holicky, E. L., Wheatley, C. L., Bernlohr, D., Marks, D. L., & Pagano, R. E. (2010) · Biochemical Journal · doi:10.1042/bj20091529 · Cited by 9
Self-citationUse of Rab GTPases to Study Lipid Trafficking in Normal and Sphingolipid Storage Disease Fibroblasts
Choudhury, A., Marks, D. L., & Pagano, R. E. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)03014-4 · Cited by 6
Self-citationSphingolipids in atherosclerosis: a metabolic underpinning of vascular disease
Rekhter, M. D., & Karathanasis, S. K. (2006) · Future Lipidology · doi:10.2217/17460875.1.5.605 · Cited by 3
The importance of cholesterol in Parkinson's disease
García‐Sanz, P., & Moratalla, R. (2018) · Movement Disorders · doi:10.1002/mds.27251 · Cited by 3
Cellular Lipid Traffic and Lipid Transporters: Regulation of Efflux and HDL Formation
Marcel, Y. L., Ouimet, M. I., & Wang, M. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_3 · Cited by 1
PROBING LIPID DOMAINS IN MODEL MEMBRANES AND IN MAMMALIAN CELLS
Koivusalo, M. (2004) · Työväentutkimus Vuosikirja
THE ROLE OF MUCOLIPIN-1 IN PATHOGENESIS OF THE LYSOSOMAL STORAGE DISEASE MUCOLIPIDOSIS TYPE IV
Miedel, M. T. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Beersel, G. V. (2013) · The Open Pathology Journal · doi:10.2174/1874375720130905003
Arsonists and Firefighters: The Perpetual Inflammatory Civil War for Survival
Karliner, J. S. (2014) · Circulation · doi:10.1161/circulationaha.114.010006
El-Banna, M. (2009) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3gh9j6b
[International Children's Day].
ECh, N. (1977) · PubMed
The Role of Sphingolipids in Cortisol Synthesis in the Adrenal Cortex
Ozbay, T. (2005) · SMARTech Repository (Georgia Institute of Technology)
Differential roles of lysosomal cholesterol transporters in the development of C. elegans NMJs
Guo, A., Wu, Q., Yan, X., Chen, K., Liu, Y., Liang, D., Yang, Y., Luo, Q., Xiong, M., Yu, Y., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402584
Analyses structurales et métaboliques de la sialylation des vertébrés
Vanbeselaere, J. (2013) · theses.fr (ABES) · doi:10.70675/f5ca88c1z90fdz4a02z94f0z2d244d6dbf4b · Cited by 1
Metadata
- Authors
- Puri, V., Jefferson, J. R., Singh, R. D., Wheatley, C. L., Marks, D. L., & Pagano, R. E.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Pagano, Richard E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 23
- Pages
- 20961-20970
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1964626438
- Cited by
- 89
- References
- 37
- Citations by year
- 2024: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 3 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6342 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM060934, GM 60934)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- sphingolipids, intracellular cholesterol accumulation, cholesterol esterification, low-density lipoprotein, late endosomes, lysosomes, endocytic compartments, endoplasmic reticulum cholesterol, ceramide, dermal fibroblasts
- MeSH terms
- Cells, Cultured, Cholesterol, DNA-Binding Proteins, Esterification, Fibroblasts, G(M1) Ganglioside, Humans, Receptors, LDL, Skin, Sphingolipids, Transcription Factors, Transcription, Genetic, CCAAT-Enhancer-Binding Proteins, Sterol Regulatory Element Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.